Skip to main content
Top
Published in: Abdominal Radiology 9/2020

01-09-2020 | Hypertension | Hepatobiliary

CT-based liver surface nodularity for the detection of clinically significant portal hypertension: defining measurement quality criteria

Authors: Riccardo Sartoris, Marie Lazareth, Arianna Nivolli, Marco Dioguardi Burgio, Valérie Vilgrain, Maxime Ronot

Published in: Abdominal Radiology | Issue 9/2020

Login to get access

Abstract

Purpose

To establish measurement quality criteria for the noninvasive assessment of clinically significant portal hypertension (CSPH) in patients with cirrhosis using CT-based liver surface nodularity (LSN) measurements.

Methods

Seventy-four consecutive patients with cirrhosis (mean 62 ± 13 years), including 30 with CSPH (41%), underwent CT and hepatic venous pressure gradient measurements. Three independent readers performed 15 LSN measurements/patient using dedicated software. LSN was computed based on the median and means of one to 15 measurements. Accuracy for diagnosing CSPH was assessed using receiver operating characteristic (ROC) curve analysis. Variability was assessed by the intra-class correlation coefficient (ICC) and the Bland–Altman plot (BA). Quality criteria were identified to maximize the accuracy of LSN and minimize variability.

Results

The area under the (AU) ROCs of mean and median LSN measurements based on one to 15 measurements ranged from 0.79 ± 0.05 to 0.91 ± 0.04 and 0.86 ± 0.04 to 0.91 ± 0.03, respectively, with no difference on pair-wise comparisons (all p > 0.05). AUROCs of LSN increased from one to eight and leveled off between eight and 15 measurements. Inter- and intra-reader variability decreased from one to 15 measurements, with only slight improvement after more than eight measurements. Intra- and inter-observer agreements were excellent with eight measurements (ICC = 0.90 [95%CI 0.84–0.94], and ICC = 0.93 [95%CI 0.89–0.95], respectively), and variability for intra-observer and inter-observer agreement was low (BA bias 4.2% (95% limits of agreement [LoA] [− 15.3; + 23.7%]) and 4.8% LoA [ − 17.5; + 27.1%], respectively).

Conclusions

CT-based LSN measurement is highly reproducible and accurate. We suggest using at least 8 valid measurements to determine the mean LSN value for the detection of CSPH.
Literature
1.
go back to reference Groszmann RJ, Wongcharatrawee S (2004) The hepatic venous pressure gradient: anything worth doing should be done right. Hepatology 39(2):280–282.PubMed Groszmann RJ, Wongcharatrawee S (2004) The hepatic venous pressure gradient: anything worth doing should be done right. Hepatology 39(2):280–282.PubMed
2.
go back to reference De Franchis R (2000) Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 33(5):846-22.PubMed De Franchis R (2000) Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 33(5):846-22.PubMed
3.
go back to reference Berzigotti, A (2017) Non-invasive evaluation of portal hypertension using ultrasound elastography. J Hepatol 67(2):399-411.PubMed Berzigotti, A (2017) Non-invasive evaluation of portal hypertension using ultrasound elastography. J Hepatol 67(2):399-411.PubMed
4.
go back to reference Berzigotti A, Seijo S, Arena U et al (2013) Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis. Gastroenterology 144:102–111.PubMed Berzigotti A, Seijo S, Arena U et al (2013) Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis. Gastroenterology 144:102–111.PubMed
5.
go back to reference Jansen C, Bogs C, Verlinden W et al (2016) Algorithm to rule out clinically significant portal hypertension combining Shear-wave elastography of liver and spleen: a prospective multicentre study. Gut 65(6):1057-8PubMed Jansen C, Bogs C, Verlinden W et al (2016) Algorithm to rule out clinically significant portal hypertension combining Shear-wave elastography of liver and spleen: a prospective multicentre study. Gut 65(6):1057-8PubMed
6.
go back to reference Sartoris R, Rautou PE, Elkrief L et al (2018) Quantification of Liver Surface Nodularity at CT: Utility for Detection of Portal Hypertension. Radiology. 289(3):698-707.PubMed Sartoris R, Rautou PE, Elkrief L et al (2018) Quantification of Liver Surface Nodularity at CT: Utility for Detection of Portal Hypertension. Radiology. 289(3):698-707.PubMed
7.
go back to reference De Vos N, Sartoris R, Cauchy F et al (2019) Performance of liver surface nodularity quantification for the diagnosis of portal hypertension in patients with cirrhosis: comparison between MRI with hepatobiliary phase sequences and CT. Abdom Radiol 45(2):365-372. De Vos N, Sartoris R, Cauchy F et al (2019) Performance of liver surface nodularity quantification for the diagnosis of portal hypertension in patients with cirrhosis: comparison between MRI with hepatobiliary phase sequences and CT. Abdom Radiol 45(2):365-372.
8.
go back to reference Degos F, Perez P, Roche B, Mahmoudi A, Asselineau J, Voitot H et al (2010) Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (theFIBROSTIC study). J Hepatol 53:1013-1021PubMed Degos F, Perez P, Roche B, Mahmoudi A, Asselineau J, Voitot H et al (2010) Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (theFIBROSTIC study). J Hepatol 53:1013-1021PubMed
9.
go back to reference Zarski JP, Sturm N, Guechot J, Paris A, Zafrani ES, Asselah T et al (2012) Comparison of 9 blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study. J Hepatol 56:55-62.PubMed Zarski JP, Sturm N, Guechot J, Paris A, Zafrani ES, Asselah T et al (2012) Comparison of 9 blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study. J Hepatol 56:55-62.PubMed
10.
go back to reference Smith AD, Branch CR, Zand K et al (2016) Liver Surface Nodularity Quantification from Routine CT Images as a Biomarker for Detection and Evaluation of Cirrhosis. Radiology 280(3):771-81.PubMed Smith AD, Branch CR, Zand K et al (2016) Liver Surface Nodularity Quantification from Routine CT Images as a Biomarker for Detection and Evaluation of Cirrhosis. Radiology 280(3):771-81.PubMed
11.
go back to reference Pickhardt PJ, Malecki K, Kloke J, Lubner MG (2016) Accuracy of Liver Surface Nodularity Quantification on MDCT as a Noninvasive Biomarker for Staging Hepatic Fibrosis. Am J Roentgenol 207(6):1194-1199. Pickhardt PJ, Malecki K, Kloke J, Lubner MG (2016) Accuracy of Liver Surface Nodularity Quantification on MDCT as a Noninvasive Biomarker for Staging Hepatic Fibrosis. Am J Roentgenol 207(6):1194-1199.
12.
go back to reference Lubner MG, Jones D, Said A et al (2018) Accuracy of liver surface nodularity quantification on MDCT for staging hepatic fibrosis in patients with hepatitis C virus. Abdom Radiol 43(11):2980-2986. Lubner MG, Jones D, Said A et al (2018) Accuracy of liver surface nodularity quantification on MDCT for staging hepatic fibrosis in patients with hepatitis C virus. Abdom Radiol 43(11):2980-2986.
13.
go back to reference Pickhardt PJ, Graffy PM, Said A, Jones D, Welsh B, Zea R, Lubner MG (2019) Multiparametric CT for Noninvasive staging of hepatitis C Virus–Related Liver Fibrosis: Correlation with the Histopathologic Fibrosis Score. Am J Roentgenol 212:547-553. Pickhardt PJ, Graffy PM, Said A, Jones D, Welsh B, Zea R, Lubner MG (2019) Multiparametric CT for Noninvasive staging of hepatitis C Virus–Related Liver Fibrosis: Correlation with the Histopathologic Fibrosis Score. Am J Roentgenol 212:547-553.
14.
go back to reference Smith AD, Zand KA, Florez E, et al (2017) Liver surface nodularity score allows prediction of cirrhosis decompensation and death. Radiology 283(3):711–722.PubMed Smith AD, Zand KA, Florez E, et al (2017) Liver surface nodularity score allows prediction of cirrhosis decompensation and death. Radiology 283(3):711–722.PubMed
15.
go back to reference Besa C, Wagner M, Lo G, Gordic S, et al (2018) Detection of liver fibrosis using qualitative and quantitative MR elastography compared to liver surface nodularity measurement, gadoxetic acid uptake, and serum markers. J Magn Reson Imaging 47(6):1552-1561.PubMed Besa C, Wagner M, Lo G, Gordic S, et al (2018) Detection of liver fibrosis using qualitative and quantitative MR elastography compared to liver surface nodularity measurement, gadoxetic acid uptake, and serum markers. J Magn Reson Imaging 47(6):1552-1561.PubMed
16.
go back to reference Lo GC, Besa C, King MJ, et al (2017) Feasibility and reproducibility of liver surface nodularity quantification for the assessment of liver cirrhosis using CT and MRI. Eur J Radiol Open 21;4:95-100. Lo GC, Besa C, King MJ, et al (2017) Feasibility and reproducibility of liver surface nodularity quantification for the assessment of liver cirrhosis using CT and MRI. Eur J Radiol Open 21;4:95-100.
17.
go back to reference Elkrief L, Ronot M, Andrade F et al (2018) Non-invasive evaluation of portal hypertension using shear-wave elastography: analysis of two algorithms combining liver and spleen stiffness in 191 patients with cirrhosis. Aliment Pharmacol Ther 47(5):621-630.PubMed Elkrief L, Ronot M, Andrade F et al (2018) Non-invasive evaluation of portal hypertension using shear-wave elastography: analysis of two algorithms combining liver and spleen stiffness in 191 patients with cirrhosis. Aliment Pharmacol Ther 47(5):621-630.PubMed
18.
go back to reference Procopet B, Berzigotti A, Abraldes JG et al (2015) Real-time shear-wave elastography: applicability, reliability and accuracy for clinically significant portal hypertension. J Hepatol. 62(5):1068-75.PubMed Procopet B, Berzigotti A, Abraldes JG et al (2015) Real-time shear-wave elastography: applicability, reliability and accuracy for clinically significant portal hypertension. J Hepatol. 62(5):1068-75.PubMed
19.
go back to reference Ferraioli G, Tinelli C, Zicchetti M et al (2012) Reproducibility of real-time shear wave elastography in the evaluation of liver elasticity. Eur J Radiol. 81(11):3102-6.PubMed Ferraioli G, Tinelli C, Zicchetti M et al (2012) Reproducibility of real-time shear wave elastography in the evaluation of liver elasticity. Eur J Radiol. 81(11):3102-6.PubMed
20.
go back to reference Smith A, Varney E, Zand K, et al (2018) Precision analysis of a quantitative CT liver surface nodularity score. Abdom Radiol 43(12):3307-3316 Smith A, Varney E, Zand K, et al (2018) Precision analysis of a quantitative CT liver surface nodularity score. Abdom Radiol 43(12):3307-3316
Metadata
Title
CT-based liver surface nodularity for the detection of clinically significant portal hypertension: defining measurement quality criteria
Authors
Riccardo Sartoris
Marie Lazareth
Arianna Nivolli
Marco Dioguardi Burgio
Valérie Vilgrain
Maxime Ronot
Publication date
01-09-2020
Publisher
Springer US
Published in
Abdominal Radiology / Issue 9/2020
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-020-02519-1

Other articles of this Issue 9/2020

Abdominal Radiology 9/2020 Go to the issue

Classics in Abdominal Radiology

The abdominal seatbelt sign

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine